NasdaqGM - Delayed Quote USD

AtriCure, Inc. (ATRC)

32.30
+0.05
+(0.16%)
At close: May 15 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
480,076
465,307
399,245
330,379
274,329
Cost of Revenue
121,192
117,783
98,875
84,439
68,469
Gross Profit
358,884
347,524
300,370
245,940
205,860
Operating Expense
393,934
387,537
327,053
288,609
253,155
Operating Income
-35,050
-40,013
-26,683
-42,669
-47,295
Net Non Operating Interest Income Expense
-1,622
-1,973
-3,133
-2,992
-4,452
Other Income Expense
-424
-1,688
-31
-537
102,134
Pretax Income
-37,096
-43,674
-29,847
-46,198
50,387
Tax Provision
1,080
1,024
591
268
188
Net Income Common Stockholders
-38,176
-44,698
-30,438
-46,466
50,199
Diluted NI Available to Com Stockholders
-38,176
-44,698
-30,438
-46,466
50,199
Basic EPS
-0.95
--
-0.66
-1.02
1.11
Diluted EPS
-0.95
--
-0.66
-1.02
1.09
Basic Average Shares
46,965
--
46,309
45,740
45,066
Diluted Average Shares
46,965
--
46,309
45,740
46,039
Total Operating Income as Reported
-35,050
-40,013
-26,683
-42,669
55,205
Total Expenses
515,126
505,320
425,928
373,048
321,624
Net Income from Continuing & Discontinued Operation
-38,176
-44,698
-30,438
-46,466
50,199
Normalized Income
-38,176
-43,622.02
-30,438
-46,466
-51,891
Interest Income
4,524
4,434
3,792
1,994
466
Interest Expense
6,146
6,407
6,925
4,986
4,918
Net Interest Income
-1,622
-1,973
-3,133
-2,992
-4,452
EBIT
-30,950
-37,267
-22,922
-41,212
55,305
EBITDA
-11,585
-18,534
-8,109
-29,502
65,746
Reconciled Cost of Revenue
121,192
117,783
98,875
84,439
68,469
Reconciled Depreciation
19,365
18,733
14,813
11,710
10,441
Net Income from Continuing Operation Net Minority Interest
-38,176
-44,698
-30,438
-46,466
50,199
Total Unusual Items Excluding Goodwill
0
-1,362
0
0
102,500
Total Unusual Items
0
-1,362
0
0
102,500
Normalized EBITDA
-11,585
-17,172
-8,109
-29,502
-36,754
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
-286.02
0
0
410
12/31/2021 - 8/5/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ANGO AngioDynamics, Inc.
9.17
-1.29%
 
AVTR.VI Avantor, Inc.
11.70
-1.68%
 
ICUI ICU Medical, Inc.
140.54
+3.39%
 
BLFS BioLife Solutions, Inc.
21.99
-0.27%
 
AZTA Azenta, Inc.
26.71
-0.85%
 
NVST Envista Holdings Corporation
18.09
+0.89%
 
SRT3.DE Sartorius Aktiengesellschaft
227.70
-0.74%
 
PLSE Pulse Biosciences, Inc.
16.49
+1.17%
 
LMAT LeMaitre Vascular, Inc.
83.30
+0.60%
 
AVR Anteris Technologies Global Corp.
3.9700
-3.17%